Anti-inflammatory agent 21 is an orally active and low-cytotoxicity anti-inflammatory compound with an IC50 of 0.76 μM against NO production; it exerts its anti-inflammatory effects by accumulating ROS and inhibiting the NF-κB/MAPK signaling pathways; it ameliorates cartilage destruction and inflammatory cell infiltration in rat models of arthritis.